Best Practice Handout - Health Plan Best Practice – Chronic Lymphocytic Leukemia (CLL)

Topic(s):

Market Insights , Cancer – Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder (lymphoid neoplasm). It is characterized by a progressive accumulation of functionally incompetent B lymphocytes, which are usually monoclonal in origin. View the fact sheet on JMCP that includes:

Current Recommended Treatments in CLL
What Oncology Specialists Recommend Various First-Line CLL Treatments
Suggested Treatment Algorithm in Patients Intolerant of 1st Generation BTK Inhibitor
Important Factors to Consider when Calculating the Total Cost of Care for CLL
Suggested CLL/SLL Treatment Pathways

For more disease state research, view the Market Insights Program.